| Accession Number: | 0000899243-22-023400 |
| Date: | 2022-06-17 |
| Issuer: | CODIAK BIOSCIENCES, INC. (CDAK) |
| Original Submission Date: |
COONEY CHARLES L
C/O CODIAK BIOSCIENCES, INC.
35 CAMBRIDGEPARK DRIVE, SUITE 500
CAMBRIDGE, MA 02140
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 2.83 | 2022-06-17 | deemed execution date | A | 7,500 (a) | 2032-06-16 | common stock 7,500 | $2.83 | 7,500 | direct | ||
| RESTRICTED STOCK UNITS | 0.0 | 2022-06-17 | deemed execution date | A | 1,500 (a) | common stock 1,500 | $0.00 | 1,500 | direct |
| ID | footnote |
|---|---|
| f1 | this option shall vest in full upon the earlier to occur of (i) june 17, 2023 and (ii) the issuer's next annual meeting of stockholders. |
| f2 | each restricted stock unit represents a contingent right to receive one share of common stock. |
| f3 | on june 17, 2022, the reporting person was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) june 17, 2023 and (ii) the issuer's next annual meeting of stockholders. |
